Tariffs Hit Hard: Constellation Brands Faces $20M Blow
Warning! GuruFocus has detected 3 Warning Sign with STZ.
The tariff pain comes at a time when beer demand isn't doing any favors either. CEO Bill Newlands told investors that while overall interest in beer hasn't faded, the number of social occasions where people actually drink it hasboth at restaurants and at home. That shift, paired with rising input costs, could pressure the company's largest earnings engine: its beer business. It's a double-whammy of softer volumes and higher costs, which could make profitability a lot harder to defend going forward.
And yet, investors didn't flinch. Shares climbed 4.7% at 12.59pm, trimming the year's losses to around 33%. The move suggests the market may have already priced in the bad newsor is betting management can absorb the blow without derailing the broader strategy. But with margins thinning and demand dynamics evolving, this could be a space to watch closely in the second half of the fiscal year.
This article first appeared on GuruFocus.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Ethereum ETF Inflows Outperform Bitcoin for the Third Day Straight
Institutional investors are flooding into Ethereum funds at nearly triple the rate of Bitcoin, providing a glimpse at how Wall Street may be positioning this year for the second-largest crypto. Ethereum exchange-traded funds clocked $704 million in inflows on Wednesday compared to Bitcoin ETFs' $86.7 million, the third consecutive day of Ethereum's dominance over the alpha coin, according to Farside Investors data. Invest in Gold American Hartford Gold: #1 Precious Metals Dealer in the Nation Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase Thor Metals Group: Best Overall Gold IRA The three-day lead has delivered $2.2 billion to ETH ETFs following Monday's record $1 billion single-day inflow, versus just $330.9 million for Bitcoin products. "Institutions are playing a key role," Peter Chung, head of research at Presto Labs, told Decrypt as Ethereum benefits from regulatory developments, including the GENIUS Act and the 'Project Crypto' speech, where SEC Chair Paul Atkins supported DeFi growth for institutions. The momentum has propelled Ethereum to $4,775, up over 60% in the past month, according to CoinGecko, and within 4% of its November 2021 all-time high near $4,900. The rally has already inflicted some pain on bearish traders, with Ethereum liquidations hitting $127.41 million in 24 hours as short positions faced pressure from rising prices, according to CoinGlass. Tom Lee's Ethereum Treasury BitMine Ups ETH Raise by $20 Billion Monthly Ethereum ETF inflows have reached $2.3 billion, equivalent to 500,000 ETH, while the network has issued only 450,000 ETH since the September 2022 merge upgrade. The supply-demand imbalance has created upward price pressure as institutional buyers absorb available supply faster than the network creates new tokens. On Wednesday, Standard Chartered revised its Ethereum price targets to $7,500 by 2025 and $25,000 by 2028, up from a previous $4,000 forecast, citing institutional buying at "nearly double the pace of Bitcoin accumulation during peak periods." Ethereum Could Soar to $25,000 by 2028: Standard Chartered Traders on Myriad Markets see an 86.9% probability that Ethereum reaches $5,000 by January 1, 2026. (Disclosure: Myriad Markets is a prediction platform developed by Dastan, parent company of Decrypt.) Digital asset treasury companies, meanwhile, continue to hoover up crypto in record fashion. That includes Tom Lee's BitMine, which just this week announced it would increase its fundraising target for buying more of the asset by $20 billion. 'When you combine record ETF inflows with corporate and sovereign balance sheet allocations, the result is deep structural demand meeting finite supply,' Rachael Lucas, crypto analyst, BTC Markets, told Decrypt. 'That's a recipe for sustained upward pressure on prices, and a sign that digital assets are firmly embedded in global capital markets,' she said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Merck KGaA's (ETR:MRK) Earnings Seem To Be Promising
Merck KGaA's (ETR:MRK) recent earnings report didn't offer any surprises, with the shares unchanged over the last week. We did some analysis to find out why and believe that investors might be missing some encouraging factors contained in the earnings. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. The Impact Of Unusual Items On Profit To properly understand Merck KGaA's profit results, we need to consider the €534m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Merck KGaA to produce a higher profit next year, all else being equal. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. Our Take On Merck KGaA's Profit Performance Unusual items (expenses) detracted from Merck KGaA's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Merck KGaA's statutory profit actually understates its earnings potential! And on top of that, its earnings per share increased by 9.2% in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. While it's really important to consider how well a company's statutory earnings represent its true earnings power, it's also worth taking a look at what analysts are forecasting for the future. Luckily, you can check out what analysts are forecasting by clicking here. This note has only looked at a single factor that sheds light on the nature of Merck KGaA's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
20 minutes ago
- Yahoo
Sculpt By Science Unveils Exclusive Program to Empower CEOs and Entrepreneurs with Peak Performance
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Sculpt By Science introduces a groundbreaking health program designed to help CEOs, entrepreneurs, and business leaders optimize their well-being, leading to enhanced professional success. Sculpt By Science Introduces Life-Changing Health Program for High-Performing Business Leaders Sculpt By Science, the leading health and fitness brand founded by Dr. Michael Gino Diamonds, is redefining how entrepreneurs and CEOs approach their health and well-being. With the launch of their exclusive DNA Sequence program, the company is offering a groundbreaking solution to help business leaders achieve not only optimal physical health but also peak mental performance, ensuring they thrive both in the boardroom and DNA Sequence program is designed for those who view health as a strategic investment, recognizing the deep connection between physical fitness and professional success. Sculpt By Science takes a unique approach that integrates medical diagnostics, fitness science, and behavior change psychology, offering high-performance solutions for entrepreneurs who demand the best in all areas of their lives. The Link Between Health and Business Success Business leaders, especially those in high-pressure environments, often face the dilemma of balancing long working hours with the need to maintain their physical and mental well-being. Sculpt By Science addresses this challenge by offering a health program that is as much about mental clarity and focus as it is about physical fitness. "Health is the foundation of success in business, but too often, executives neglect it in the pursuit of their goals," said Dr. Michael Diamonds, Founder of Sculpt By Science. "The DNA Sequence program is designed to help high performers unlock their full potential by integrating science-backed health strategies into their busy lives. When you feel better, you perform better, this is what we're proving with every client we serve." Personalized Plans with a Focus on Peak Performance Sculpt By Science's DNA Sequence program goes beyond traditional fitness plans by offering a tailored approach for each client, starting with a comprehensive health assessment. This includes advanced testing, such as hormone analysis, gut health mapping, and DEXA scans, that ensures each program is uniquely suited to the client's needs. From there, a personalized fitness and wellness plan is created, taking into account the client's lifestyle, goals, and challenges. The program incorporates everything from physical training to stress management, sleep optimization, and nutritional guidance, all while aligning with the fast-paced schedules of busy professionals. One key feature of the program is its emphasis on identity transformation. Rather than simply focusing on temporary results, Sculpt By Science helps clients cultivate the mindset of a "Business Athlete." This concept encourages executives to treat their bodies as their most important asset, investing in their health the same way they would in their businesses. "The transformation is not just about losing weight or getting stronger," Dr. Diamonds explained. "It's about shifting the way our clients think about themselves. A Business Athlete understands that true success requires optimal health, and the DNA Sequence program is the pathway to unlocking that potential." Exclusive Support and Community for High Performers In addition to personalized health plans, the DNA Sequence program offers an unparalleled level of support. Clients gain access to weekly one-on-one consultations with Dr. Diamonds and his team of medical professionals, as well as 24/7 messaging support. This ensures that clients stay on track and can make adjustments as needed in real-time. The program also fosters a close-knit community of like-minded business leaders who are committed to achieving their best health. Sculpt By Science offers exclusive mastermind groups and private retreats, creating opportunities for clients to network, share experiences, and collaborate with others who share similar goals. "Our clients don't just get a fitness plan, they get a community of high achievers who are all focused on achieving peak performance," said Dr. Diamonds. "The mastermind events and private retreats give our clients the opportunity to connect with others who understand the pressures of leading a business. It's a place where they can learn, grow, and be inspired." Real Results for Busy Professionals Sculpt By Science is already seeing incredible success with its DNA Sequence program, having helped over 2,000 clients transform their health and business performance. High-profile entrepreneurs, CEOs, and executives have experienced life-changing results, from fat loss and muscle gain to improved energy and mental clarity. One client, a Silicon Valley entrepreneur, shared: "The DNA Sequence program didn't just help me lose weight, it gave me the energy and clarity to lead my company to new heights. I've never felt this focused and confident in my business." Another client, a CEO, said: "Before Sculpt By Science, I struggled with maintaining my health while managing my business. Now, I feel stronger, healthier, and more driven than ever. My physical health has truly become the foundation of my business success." The Future of Executive Health Sculpt By Science's DNA Sequence program is setting a new standard for health and fitness in the business world. As the program continues to gain momentum, more and more entrepreneurs and executives are realizing the direct connection between health optimization and business success. "We believe that health is the ultimate competitive edge," Dr. Diamonds said. "By optimizing physical health and mental performance, our clients are able to lead their businesses with clarity, focus, and confidence. This is the future of executive health, and we're excited to be at the forefront of this movement." For more information about Sculpt By Science and how to apply for the DNA Sequence program, visit About Sculpt By Science Sculpt By Science is a premium health and fitness brand focused on helping high-performing entrepreneurs, CEOs, and business leaders optimize their health for peak performance. Founded by Dr. Michael Diamonds, a medical doctor and fitness expert, Sculpt By Science combines advanced diagnostics with personalized fitness plans to deliver transformative results. With over 2,000 clients served, Sculpt By Science is helping executives unlock their full potential and achieve sustained success. Media Contact: Dr. Michael Gino DiamondsFounder & CEO, Sculpt By ScienceEmail: mikediamonds23@ Website: @DoctorMikeDiamondsInstagram: @ Disclaimer: This press release is provided by Sculpt By Science. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing involves significant risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Legal Disclaimer: This media platform provides the content of this article on an "as-is" basis, without any warranties or representations of any kind, express or implied. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above. A photo accompanying this announcement is available at while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
